2025 International Fall Summit
October 15, 2025 | 12:00 PM EST
Medically Integrated Oncology Treatment Discussion Guide
Last Updated: June 23, 2025
Empowering the Entire Oncology Team
Delivering high-quality, patient-centered education requires every member of the medically integrated team working in sync—each bringing their expertise to the table in a way that supports, informs, and empowers patients. That’s the mission behind NCODA’s newest resource: the Medically Integrated Oncology Treatment Discussion Guide.
This structured discussion guide equips oncologists, pharmacists, advanced practice providers, pharmacy technicians, and nurses with tailored insights to elevate treatment conversations at every step. Whether explaining the intent of therapy or addressing financial concerns, the guide ensures consistency in messaging while honoring the unique role each team member plays in the patient experience.
Key Features of the Guide Include:
- Role-Specific Questions & Recommendations
Practical, thoughtful prompts that encourage open dialogue with patients—customized for each team role. - Actionable Patient Education Pearls
Guidance on topics like adherence, drug interactions, monitoring, financial support, and more. - Patient-Centered Approach
Every section is designed to support better understanding, emotional reassurance, and proactive care.
This guide doesn’t replace clinical judgment—it empowers it. Use it as a tool to structure conversations, align messaging, and foster true teamwork in support of optimal patient outcomes.
Download the Medically Integrated Oncology Treatment Discussion Guide for zanubrutinib today to begin enhancing your treatment conversations. This is the first in a growing series, with additional guides for other therapies currently in development and coming soon.